Nimotop and vasospasm Patient Reports February 11, 2012

Nimotop Side Effects Report #4778929-4
Nimotop side effect was reported by a Consumer or non-health professional from BELGIUM on Mar 21, 2005. Male patient, 59 years of age, weighting 180.8 lb, was diagnosed with aneurysm , subarachnoid haemorrhage and was treated with Nimotop. After drug was administered, patient experienced the following side effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm. Nimotop dosage: 10 ML, Q1HR, INTRAVENOUS. During the same period patient was treated with PERFUSALGAN, ACTRAPID, ZANTAC, FRAXIPARINE. Patient recovered.

Nimotop Side Effects Report #4596344-3
Nimotop side effect was reported by a Consumer or non-health professional from on Feb 17, 2005. Male patient, 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm , subarachnoid haemorrhage and was treated with Nimotop. After drug was administered, patient experienced the following side effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm. Nimotop dosage: 10 ML, Q1HR, INTRAVENOUS. During the same period patient was treated with PERFUSALGAN, ACTRAPID, ZANTAC, FRAXIPARINE. Patient recovered.

Nimotop Side Effects Report #4638424-X
Nimotop side effect was reported by a Health Professional from on Mar 21, 2005. Male patient, 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm , subarachnoid haemorrhage and was treated with Nimotop. After drug was administered, patient experienced the following side effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm. Nimotop dosage: 10 ML, Q1HR , INTRAVENOUS. During the same period patient was treated with PERFUSALGAN, ACTRAPID, ZANTAC, FRAXIPARINE. Patient recovered.

Nimotop Side Effects Report #4778783-0
Nimotop side effect was reported by a Consumer or non-health professional from BELGIUM on Mar 21, 2005. Male patient, 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm , subarachnoid haemorrhage and was treated with Nimotop. After drug was administered, patient experienced the following side effects: catheter related complication, neurological symptom, post procedural complication, vasospasm. Nimotop dosage: 10 ML, Q1HR, INTRAVENOUS. During the same period patient was treated with PERFUSALGAN, ACTRAPID, ZANTAC, FRAXIPARINE. Patient recovered.